Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, mainly due to its late diagnosis and lack of effective therapies, translating into a low 5-year 12% survival rate, despite extensive clinical efforts to improve outcomes. International cooperative studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Alors-Pérez, Emilia, Pedraza-Arevalo, Sergio, Blázquez-Encinas, Ricardo, Moreno-Montilla, María Trinidad, García-Vioque, Víctor, Berbel, Inmaculada, Luque, Raúl M., Sainz, Bruno, Ibáñez-Costa, Alejandro, Castaño, Justo P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601233/
https://www.ncbi.nlm.nih.gov/pubmed/37880792
http://dx.doi.org/10.1186/s13046-023-02858-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601233/
https://www.ncbi.nlm.nih.gov/pubmed/37880792
http://dx.doi.org/10.1186/s13046-023-02858-z

Ejemplares similares